Loomis Sayles & CO L P Johnson & Johnson Transaction History

Loomis Sayles & CO L P

$76.2 Billion
Q3 2024

A detailed history of Loomis Sayles & CO L P transactions in Johnson & Johnson stock. As of the latest transaction made, Loomis Sayles & CO L P holds 87,611 shares of JNJ stock, worth $13.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

87,611

Previous 60,742 44.23%

Holding current value

$13.6 Million

Previous $8.88 Million 59.92%

% of portfolio

0.02%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$145.48 - $167.38 $3.91 Million - $4.5 Million	26,869 Added 44.23%	87,611 $14.2 Million
Q2 2024 Aug 13, 2024	BUY	$144.38 - $157.78 $715,836 - $782,273	4,958 Added 8.89%	60,742 $8.88 Million
Q1 2024 May 14, 2024	BUY	$155.22 - $162.74 $2.72 Million - $2.85 Million	17,513 Added 45.76%	55,784 $8.83 Million
Q4 2023 Feb 13, 2024	BUY	$145.6 - $158.88 $1.61 Million - $1.75 Million	11,040 Added 40.54%	38,271 $6 Million
Q3 2023 Nov 09, 2023	SELL	$155.75 - $174.48 $363,987 - $407,759	-2,337 Reduced 7.9%	27,231 $4.24 Million
Q2 2023 Aug 11, 2023	SELL	$154.35 - $166.11 $2.38 Million - $2.56 Million	-15,396 Reduced 34.24%	29,568 $4.9 Million
Q1 2023 May 11, 2023	SELL	$151.05 - $180.26 $40,632 - $48,489	-269 Reduced 0.59%	44,964 $6.97 Million
Q4 2022 Feb 10, 2023	SELL	$160.2 - $179.79 $153,952 - $172,778	-961 Reduced 2.08%	45,233 $7.99 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $21.6 Million - $24 Million	-133,890 Reduced 74.35%	46,194 $7.55 Million
Q2 2022 Aug 05, 2022	SELL	$168.19 - $186.01 $19.2 Million - $21.3 Million	-114,321 Reduced 38.83%	180,084 $32 Million
Q1 2022 May 13, 2022	BUY	$158.14 - $179.59 $5.7 Million - $6.48 Million	36,059 Added 13.96%	294,405 $52.2 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $6.94 Million - $7.7 Million	-44,513 Reduced 14.7%	258,346 $44.2 Million
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $2.53 Million - $2.81 Million	15,640 Added 5.45%	302,859 $48.9 Million
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $3.93 Million - $4.22 Million	-24,653 Reduced 7.9%	287,219 $47.3 Million
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $31.4 Million - $35 Million	205,405 Added 192.93%	311,872 $51.3 Million
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $12.6 Million - $14.4 Million	91,560 Added 614.21%	106,467 $16.8 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $29,339 - $32,150	-209 Reduced 1.38%	14,907 $2.22 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $117,989 - $142,447	-916 Reduced 5.71%	15,116 $2.13 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $411,773 - $570,532	-3,705 Reduced 18.77%	16,032 $2.1 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $1.66 Million - $1.91 Million	-13,033 Reduced 39.77%	19,737 $2.88 Million
Q3 2019 Nov 13, 2019	SELL	$126.95 - $142.14 $33,895 - $37,951	-267 Reduced 0.81%	32,770 $4.24 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $455,221 - $500,657	-3,471 Reduced 9.51%	33,037 $4.6 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $988,662 - $1.1 Million	7,864 Added 27.45%	36,508 $5.1 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $1.92 Million - $2.32 Million	-15,668 Reduced 35.36%	28,644 $3.7 Million
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $4.81 Million - $5.66 Million	-39,595 Reduced 47.19%	44,312 $6.12 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $7.73 Million - $8.53 Million	-64,756 Reduced 43.56%	83,907 $10.2 Million
Q1 2018 May 11, 2018	BUY	$125.1 - $148.14 $18.6 Million - $22 Million	148,663 New	148,663 $19.1 Million
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $3.39 Million - $3.55 Million	-26,213 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	26,213	26,213 $3.47 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Account

Loomis Sayles & CO L P Johnson & Johnson Transaction History